Skip to main content
Clinical Trials/NCT05445817
NCT05445817
Unknown
Not Applicable

Pulmonary Care and Research Collaborative Patient Registry

Pulmonary Care and Research Collaborative Limited1 site in 1 country150 target enrollmentJuly 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Interstitial Lung Disease
Sponsor
Pulmonary Care and Research Collaborative Limited
Enrollment
150
Locations
1
Primary Endpoint
Development and implementation of a database populated with de-identified longitudinal medical histories of interstitial lung disease patients.
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this research study is to build and maintain a registry of people with interstitial lung disease (ILD). Medical information collected for this registry may be used to advance ILD and pulmonary research and improve patient care. This is an observational registry. Participants will not receive any investigational treatments or investigational drugs as part of their participation in this registry.

Detailed Description

The registry will contain longitudinal medical histories of ILD patients. The creation and curation of the registry with utilize release of information services, biomedical informatics methods and human expert reviews. Among the registry's long-term goals is to utilize its data and informatics resources to study and advance ILD diagnosis and treatment. The registry will be developed with a set of capabilities to consistently, repeatedly, and economically build research-grade datasets that allow cohort development from natively unstructured and non-standard phenotypic clinical and imaging data.

Registry
clinicaltrials.gov
Start Date
July 2022
End Date
March 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Pulmonary Care and Research Collaborative Limited
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • People with a confirmed diagnosis of interstitial lung disease by a primary care physician and/or pulmonologist.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Development and implementation of a database populated with de-identified longitudinal medical histories of interstitial lung disease patients.

Time Frame: Up to 18 months

Secondary Outcomes

  • Advancing the understanding of the natural course and the treatments of interstitial lung diseases.(Up to 18 months)

Study Sites (1)

Loading locations...

Similar Trials